A balance between mitochondrial membrane fusion and fission is required for normal mitochondrial morphology and function. Shifts in mitochondrial morphology as a result of changes in the balance of membrane fusion and fission accompany cellular differentiation and changes in metabolic state. It is thought that the severe, early-onset peripheral neuropathy Charcot-Marie-Tooth type 2A disease is a manifestation of mitochondrial fusion malfunction as a result of a mutation of one of the two human mitofusins, mitofusin 2. Our aim is to reveal the mechanism by which mitofusins cause membrane fusion. Both mammalian mitofusins contain a large GTPase domain at their N-terminus followed by two transmembrane domains and a short C-terminal domain. It is predicted that GTP hydrolysis and mitofusin conformational changes are coupled to membrane fusion. However, the precise mechanism for mitofusin-mediated membrane fusion remains an open question. In fact, it is still unknown if mitochondrial outer membrane fusion proceeds through the canonical steps of tethering, docking, fusion, and disassembly. To gain insight into the conformational changes that lead to membrane fusion we are examining the structure of mitofusins in a lipid bilayer. As two-pass transmembrane proteins, mitofusins have proven difficult to express and purify in their full-length state and are poor candidates for crystallography. Here we present a purification strategy and the first cryo-em images of full-length mitofusins in a lipid bilayer. In addition, we show that mitofusins tether proteolipsosomes by forming oligomers that interact in trans between synthetic membranes. This implies that mitofusins are sufficient for driving the first step of membrane fusion.